B-CELL ACUTE LYMPHOCYTIC LEUKEMIA

Clinical trials for B-CELL ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new B-CELL ACUTE LYMPHOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New CAR-T therapy trial aims to control tough leukemia

Disease control Recruiting now

This study is testing whether a personalized immune cell therapy (called brexucabtagene autoleucel or brexu-cel) can help control B-cell acute lymphocytic leukemia (ALL) in adults. It is for people whose cancer has come back or didn't respond to treatment, or for those newly diag…

Matched conditions: B-CELL ACUTE LYMPHOCYTIC LEUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

B-CELL ACUTE LYMPHOCYTIC LEUKEMIA

Get alerted when new B-CELL ACUTE LYMPHOCYTIC LEUKEMIA trials appear

New CAR-T therapy trial aims to control tough leukemia